North America In-vitro Toxicology Testing Market Size & Outlook
North America in-vitro toxicology testing market, 2018-2030 (US$M)
Related Markets
North America in-vitro toxicology testing market highlights
- The North America in-vitro toxicology testing market generated a revenue of USD 14,810.4 million in 2023.
- The market is expected to grow at a CAGR of 11.8% from 2024 to 2030.
- In terms of segment, pharmaceutical industry was the largest revenue generating end user in 2023.
- Diagnostics is the most lucrative end user segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 14,810.4 million |
| Market revenue in 2030 | USD 32,265.4 million |
| Growth rate | 11.8% (CAGR from 2023 to 2030) |
| Largest segment | Pharmaceutical industry |
| Fastest growing segment | Diagnostics |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pharmaceutical Industry, Cosmetics And Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemicals Industry, Food Industry |
| Key market players worldwide | Charles River Laboratories International Inc, SGS, Merck KGaA, Eurofins Scientific SE, Abbott Laboratories, Labcorp Holdings Inc, Evotec SE, Thermo Fisher Scientific Inc, Quest Diagnostics Inc, Agilent Technologies Inc, Catalent Inc, Danaher Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 47.7% of the global in-vitro toxicology testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 32,265.4 million by 2030.
Pharmaceutical industry was the largest segment with a revenue share of 43.24% in 2023. Horizon Databook has segmented the North America in-vitro toxicology testing market based on pharmaceutical industry, cosmetics and household products, academic institutes and research laboratories, diagnostics, chemicals industry, food industry covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the major share of the global in-vitro toxicology testing market owing to the increased focus of government bodies on drug discovery, rise in healthcare expenditure, and the presence of adequate infrastructure for the growth & development of drug discovery technologies.
Recent advancements and new government regulations pertaining to drug development have contributed to the rapid launch of novel, cost-effective, nonanimal testing approaches for the safety testing of new products across various industries including devices, chemicals, and cosmetics.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
In-vitro Toxicology Testing Market Scope
In-vitro Toxicology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America in-vitro toxicology testing market size, by country, 2018-2030 (US$M)
North America In-vitro Toxicology Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
